Gallus gallus isolate bGalGal1 chromosome 26, bGalGal1.mat.broiler.GRCg7b, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Gallus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028507.1.\nAssembly name: bGalGal1.mat.broiler.GRCg7b\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/01/19. The original whole-genome shotgun project has the\naccession JAENSK000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 22-JUL-2020\nAssembly Method :: TrioCanu v. 1.8; purge_dups v. 1.0.0;\n Scaff 10x v. 4.1.0; Bionano solve v.\n 3.2.1_04122018; Salsa2 HiC v. 2.2; Arrow\n polishing and gap filling v.\n SMRTLink7.0.1; Freebayes v. 1.3.1; gEVAL\n manual curation v. 2020-07-22; VGP trio\n assembly pipeline v. 1.6\nAssembly Name :: bGalGal1.mat.broiler.GRCg7b\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 102.01x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Gallus gallus Annotation Release 106\nAnnotation Version :: 106\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC112530333, transcript variant X6
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
uncharacterized LOC112530333, transcript variant X5
uncharacterized LOC112530333, transcript variant X4
uncharacterized LOC112530333, transcript variant X2
uncharacterized LOC112530333, transcript variant X9
uncharacterized LOC112530333, transcript variant X8
uncharacterized LOC112530333, transcript variant X7
uncharacterized LOC112530333, transcript variant X1
uncharacterized LOC112530333, transcript variant X10
uncharacterized LOC112530333, transcript variant X3
lymphoid-restricted membrane protein-like, transcript variant X1
lymphoid-restricted membrane protein-like, transcript variant X7
lymphoid-restricted membrane protein-like, transcript variant X18
lymphoid-restricted membrane protein-like, transcript variant X6
lymphoid-restricted membrane protein-like, transcript variant X25
lymphoid-restricted membrane protein-like, transcript variant X11
lymphoid-restricted membrane protein-like, transcript variant X16
lymphoid-restricted membrane protein-like, transcript variant X5
lymphoid-restricted membrane protein-like, transcript variant X22
lymphoid-restricted membrane protein-like, transcript variant X10
lymphoid-restricted membrane protein-like, transcript variant X3
lymphoid-restricted membrane protein-like, transcript variant X20
lymphoid-restricted membrane protein-like, transcript variant X9
lymphoid-restricted membrane protein-like, transcript variant X31
lymphoid-restricted membrane protein-like, transcript variant X2
lymphoid-restricted membrane protein-like, transcript variant X14
lymphoid-restricted membrane protein-like, transcript variant X27
lymphoid-restricted membrane protein-like, transcript variant X21
lymphoid-restricted membrane protein-like, transcript variant X13
lymphoid-restricted membrane protein-like, transcript variant X4
lymphoid-restricted membrane protein-like, transcript variant X12
lymphoid-restricted membrane protein-like, transcript variant X24
lymphoid-restricted membrane protein-like, transcript variant X8
lymphoid-restricted membrane protein-like, transcript variant X15
lymphoid-restricted membrane protein-like, transcript variant X19
lymphoid-restricted membrane protein-like, transcript variant X17
lymphoid-restricted membrane protein-like, transcript variant X30
lymphoid-restricted membrane protein-like, transcript variant X28
lymphoid-restricted membrane protein-like, transcript variant X34
lymphoid-restricted membrane protein-like, transcript variant X23
lymphoid-restricted membrane protein-like, transcript variant X26
lymphoid-restricted membrane protein-like, transcript variant X29
lymphoid-restricted membrane protein-like, transcript variant X33
lymphoid-restricted membrane protein-like, transcript variant X32
lymphoid-restricted membrane protein-like, transcript variant X35
lymphoid-restricted membrane protein-like, transcript variant X36
inositol 1,4,5-triphosphate receptor associated 2 isoform X1
inositol 1,4,5-triphosphate receptor associated 2 isoform X11
inositol 1,4,5-triphosphate receptor associated 2 isoform X10
inositol 1,4,5-triphosphate receptor associated 2 isoform X9
inositol 1,4,5-triphosphate receptor associated 2 isoform X21
inositol 1,4,5-triphosphate receptor associated 2 isoform X13
inositol 1,4,5-triphosphate receptor associated 2 isoform X4
inositol 1,4,5-triphosphate receptor associated 2 isoform X15
inositol 1,4,5-triphosphate receptor associated 2 isoform X28
inositol 1,4,5-triphosphate receptor associated 2 isoform X6
inositol 1,4,5-triphosphate receptor associated 2 isoform X16
inositol 1,4,5-triphosphate receptor associated 2 isoform X5
inositol 1,4,5-triphosphate receptor associated 2 isoform X3
inositol 1,4,5-triphosphate receptor associated 2 isoform X2
inositol 1,4,5-triphosphate receptor associated 2 isoform X14
inositol 1,4,5-triphosphate receptor associated 2 isoform X8
inositol 1,4,5-triphosphate receptor associated 2 isoform X19
inositol 1,4,5-triphosphate receptor associated 2 isoform X17
inositol 1,4,5-triphosphate receptor associated 2 isoform X23
inositol 1,4,5-triphosphate receptor associated 2 isoform X7
inositol 1,4,5-triphosphate receptor associated 2 isoform X18
inositol 1,4,5-triphosphate receptor associated 2 isoform X27
inositol 1,4,5-triphosphate receptor associated 2 isoform X12
inositol 1,4,5-triphosphate receptor associated 2 isoform X24
inositol 1,4,5-triphosphate receptor associated 2 isoform X30
inositol 1,4,5-triphosphate receptor associated 2 isoform X33
inositol 1,4,5-triphosphate receptor associated 2 isoform X25
inositol 1,4,5-triphosphate receptor associated 2 isoform X22
inositol 1,4,5-triphosphate receptor associated 2 isoform X20
inositol 1,4,5-triphosphate receptor associated 2 isoform X31
inositol 1,4,5-triphosphate receptor associated 2 isoform X26
inositol 1,4,5-triphosphate receptor associated 2 isoform X32
inositol 1,4,5-triphosphate receptor associated 2 isoform X29
inositol 1,4,5-triphosphate receptor associated 2 isoform X34
inositol 1,4,5-triphosphate receptor associated 2 isoform X35
microtubule associated monooxygenase, calponin and LIM domain containing 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 1
Derived by automated computational analysis using gene prediction method: BestRefSeq.
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
sphingomyelin phosphodiesterase 2, transcript variant X2
sphingomyelin phosphodiesterase 2, transcript variant X1
sphingomyelin phosphodiesterase 2, transcript variant X4
sphingomyelin phosphodiesterase 2, transcript variant X3
sphingomyelin phosphodiesterase 2, transcript variant X5
sphingomyelin phosphodiesterase 2 isoform X2
sphingomyelin phosphodiesterase 2 isoform X1
TEA domain transcription factor 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
TEA domain transcription factor 3, transcript variant X2
TEA domain transcription factor 3, transcript variant X4
TEA domain transcription factor 3, transcript variant X1
TEA domain transcription factor 3, transcript variant X3
transcriptional enhancer factor TEF-5 isoform X3
transcriptional enhancer factor TEF-5 isoform X2
transcriptional enhancer factor TEF-5 isoform X4
transcriptional enhancer factor TEF-5 isoform X1
tubby like protein 1, transcript variant X3
tubby like protein 1, transcript variant X1
tubby like protein 1, transcript variant X2
FK506 binding protein 5; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
FK506 binding protein 5, transcript variant X3
FK506 binding protein 5, transcript variant X5
FK506 binding protein 5, transcript variant X1
FK506 binding protein 5, transcript variant X2
FK506 binding protein 5, transcript variant X4
similar to RNA sequence, mRNA (same species):RefSeq:NM_001005431.1
annotated by transcript or proteomic data
The RefSeq transcript has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X2
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X1
peptidyl-prolyl cis-trans isomerase FKBP5
colipase; Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
lipoma HMGIC fusion partner-like 5; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
lipoma HMGIC fusion partner-like 5, transcript variant X1
LHFPL tetraspan subfamily member 5 protein isoform X1
LHFPL tetraspan subfamily member 5 protein
propagated from UniProtKB/Swiss-Prot (Q7ZZL8.1); transmembrane region
SRSF protein kinase 1, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
SRSF protein kinase 1, transcript variant X1
SRSF protein kinase 1, transcript variant X3
solute carrier family 26 member 8, transcript variant X9
solute carrier family 26 member 8, transcript variant X3
solute carrier family 26 member 8, transcript variant X4
solute carrier family 26 member 8, transcript variant X10
solute carrier family 26 member 8, transcript variant X1
solute carrier family 26 member 8, transcript variant X12
solute carrier family 26 member 8, transcript variant X6
solute carrier family 26 member 8, transcript variant X2
solute carrier family 26 member 8, transcript variant X5
solute carrier family 26 member 8, transcript variant X11
solute carrier family 26 member 8, transcript variant X8
solute carrier family 26 member 8, transcript variant X7
mitogen-activated protein kinase 14, transcript variant X1
mitogen-activated protein kinase 14, transcript variant X2
mitogen-activated protein kinase 14, transcript variant X3
mitogen-activated protein kinase 14 isoform X1
mitogen-activated protein kinase 14 isoform X2
mitogen-activated protein kinase 13, transcript variant X1
mitogen-activated protein kinase 13, transcript variant X2
mitogen-activated protein kinase 13 isoform X1
mitogen-activated protein kinase 13 isoform X2
uncharacterized LOC771161, transcript variant X1
bromodomain and PHD finger containing, 3, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: bromodomain and PHD finger-containing protein 3
TBC1 domain family member 22B, transcript variant X2
TBC1 domain family member 22B, transcript variant X1
TBC1 domain family member 22B, transcript variant X4
TBC1 domain family member 22B, transcript variant X3
TBC1 domain family member 22B isoform X2
TBC1 domain family member 22B isoform X1
TBC1 domain family member 22B isoform X3
TBC1 domain family member 22B isoform X4
uncharacterized LOC101747295, transcript variant X1
uncharacterized LOC101747295, transcript variant X2
uncharacterized LOC101747295, transcript variant X3
Pim-1 proto-oncogene, serine/threonine kinase
calcium voltage-gated channel subunit alpha1 S; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
calcium voltage-gated channel subunit alpha1 S, transcript variant X2
calcium voltage-gated channel subunit alpha1 S, transcript variant X3
calcium voltage-gated channel subunit alpha1 S, transcript variant 2
calcium voltage-gated channel subunit alpha1 S, transcript variant 1
calcium voltage-gated channel subunit alpha1 S, transcript variant X1
voltage-dependent L-type calcium channel subunit alpha-1S
voltage-dependent L-type calcium channel subunit alpha-1S isoform X2
voltage-dependent L-type calcium channel subunit alpha-1S isoform X3
voltage-dependent L-type calcium channel subunit alpha-1S isoform X1
kinesin family member 21B, transcript variant X3
kinesin family member 21B, transcript variant X4
kinesin family member 21B, transcript variant X1
kinesin family member 21B, transcript variant X2
G protein-coupled receptor 37 like 1, transcript variant X1
G protein-coupled receptor 37 like 1, transcript variant X2
ADP ribosylation factor like GTPase 8A; Derived by automated computational analysis using gene prediction method: BestRefSeq.
protein tyrosine phosphatase, non-receptor type 7, transcript variant X4
protein tyrosine phosphatase, non-receptor type 7, transcript variant X3
protein tyrosine phosphatase, non-receptor type 7, transcript variant X1
protein tyrosine phosphatase, non-receptor type 7, transcript variant X2
protein tyrosine phosphatase, non-receptor type 7, transcript variant X5
tyrosine-protein phosphatase non-receptor type 7 isoform X1
protein tyrosine phosphatase, non-receptor type 7, transcript variant X6
tyrosine-protein phosphatase non-receptor type 7 isoform X2
protein tyrosine phosphatase, receptor type, V, pseudogene, transcript variant X1
protein tyrosine phosphatase, receptor type, V, pseudogene, transcript variant X2
receptor-type tyrosine-protein phosphatase V isoform X1
receptor-type tyrosine-protein phosphatase V isoform X2
protein tyrosine phosphatase, receptor type, V, pseudogene, transcript variant X3
receptor-type tyrosine-protein phosphatase V isoform X3
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X1
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X2
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X2
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X3
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X3
zinc finger CCCH-type containing 11A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
zinc finger CCCH-type containing 11A, transcript variant X5
zinc finger CCCH-type containing 11A, transcript variant X7
zinc finger CCCH-type containing 11A, transcript variant X10
zinc finger CCCH-type containing 11A, transcript variant X1
zinc finger CCCH-type containing 11A, transcript variant X4
zinc finger CCCH-type containing 11A, transcript variant X2
zinc finger CCCH-type containing 11A, transcript variant X8
zinc finger CCCH-type containing 11A, transcript variant X3
zinc finger CCCH-type containing 11A, transcript variant X6
zinc finger CCCH-type containing 11A, transcript variant X9
zinc finger CCCH domain-containing protein 11A isoform X1
zinc finger CCCH domain-containing protein 11A
propagated from UniProtKB/Swiss-Prot (Q5ZJJ1.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
zinc finger CCCH domain-containing protein 11A isoform X2
negative elongation factor complex member E
uncharacterized LOC121107603, transcript variant X1
tubulin, alpha 5; Derived by automated computational analysis using gene prediction method: BestRefSeq.
lysine demethylase 5B; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
propagated from UniProtKB/Swiss-Prot (Q5F3R2.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
lysine demethylase 5B, transcript variant X1
lysine-specific demethylase 5B isoform X1
leucine zipper like transcription regulator 1, transcript variant X2
leucine zipper like transcription regulator 1, transcript variant X1
leucine-zipper-like transcriptional regulator 1 isoform X1
leucine-zipper-like transcriptional regulator 1 isoform X2
arginyl aminopeptidase, transcript variant X1
arginyl aminopeptidase, transcript variant X2
neuron navigator 1, transcript variant X3
neuron navigator 1, transcript variant X1
neuron navigator 1, transcript variant X2
neuron navigator 1, transcript variant X6
neuron navigator 1, transcript variant X7
neuron navigator 1, transcript variant X8
neuron navigator 1, transcript variant X5
neuron navigator 1, transcript variant X4
protein phosphatase 1 regulatory subunit 12B, transcript variant X14
protein phosphatase 1 regulatory subunit 12B, transcript variant X16
protein phosphatase 1 regulatory subunit 12B, transcript variant X3
protein phosphatase 1 regulatory subunit 12B, transcript variant X15
protein phosphatase 1 regulatory subunit 12B, transcript variant X8
protein phosphatase 1 regulatory subunit 12B, transcript variant X6
protein phosphatase 1 regulatory subunit 12B, transcript variant X18
protein phosphatase 1 regulatory subunit 12B, transcript variant X17
protein phosphatase 1 regulatory subunit 12B, transcript variant X2
protein phosphatase 1 regulatory subunit 12B, transcript variant X13
protein phosphatase 1 regulatory subunit 12B, transcript variant X11
protein phosphatase 1 regulatory subunit 12B, transcript variant X1
protein phosphatase 1 regulatory subunit 12B, transcript variant X12
protein phosphatase 1 regulatory subunit 12B isoform X8
protein phosphatase 1 regulatory subunit 12B isoform X10
protein phosphatase 1 regulatory subunit 12B isoform X2
protein phosphatase 1 regulatory subunit 12B isoform X9
protein phosphatase 1 regulatory subunit 12B isoform X7
protein phosphatase 1 regulatory subunit 12B isoform X5
protein phosphatase 1 regulatory subunit 12B isoform X1
protein phosphatase 1 regulatory subunit 12B isoform X6
protein phosphatase 1 regulatory subunit 12B, transcript variant X10
microRNA 6607; Derived by automated computational analysis using gene prediction method: BestRefSeq.
protein phosphatase 1 regulatory subunit 12B, transcript variant X9
protein phosphatase 1 regulatory subunit 12B, transcript variant X7
protein phosphatase 1 regulatory subunit 12B, transcript variant X5
protein phosphatase 1 regulatory subunit 12B, transcript variant X4
protein phosphatase 1 regulatory subunit 12B isoform X4
protein phosphatase 1 regulatory subunit 12B isoform X3
cysteine and glycine rich protein 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
cysteine and glycine rich protein 1, transcript variant X2
cysteine and glycine rich protein 1, transcript variant X3
cysteine and glycine rich protein 1, transcript variant X1
cysteine and glycine-rich protein 1 isoform X1
propagated from UniProtKB/Swiss-Prot (P67966.2); Region: Nuclear localization signal. /evidence=ECO:0000255
cysteine and glycine rich protein 1, transcript variant X4
cysteine and glycine-rich protein 1 isoform X2
pleckstrin homology like domain family A member 3
pleckstrin homology-like domain family A member 3
troponin I type 1 (skeletal, slow), transcript variant X1
troponin I type 1 (skeletal, slow), transcript variant X2
troponin I, slow skeletal muscle isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
troponin T2, cardiac type; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
troponin T2, cardiac type, transcript variant X3
troponin T2, cardiac type, transcript variant X1
troponin T2, cardiac type, transcript variant X5
troponin T2, cardiac type, transcript variant X2
troponin T2, cardiac type, transcript variant X4
troponin T2, cardiac type, transcript variant X6
troponin T, cardiac muscle isoforms isoform X1
propagated from UniProtKB/Swiss-Prot (P02642.2); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
N-acetylserine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P02642.2); acetylation site
Phosphoserine, by CK2. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P02642.2); phosphorylation site
troponin T, cardiac muscle isoforms isoform X2
troponin T, cardiac muscle isoforms isoform X3
troponin T, cardiac muscle isoforms isoform X4
immunoglobulin-like and fibronectin type III domain containing 1
immunoglobulin-like and fibronectin type III domain-containing protein 1
transmembrane protein 9, transcript variant X1
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X1
transmembrane protein 9, transcript variant X2
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X2
MGAT4 family member C; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
MGAT4 family member C, transcript variant 7
MGAT4 family member C, transcript variant 5
MGAT4 family member C, transcript variant 4
MGAT4 family member C, transcript variant 6
MGAT4 family member C, transcript variant 2
MGAT4 family member C, transcript variant 1
MGAT4 family member C, transcript variant 3
MGAT4 family member C, transcript variant X3
MGAT4 family member C, transcript variant X4
MGAT4 family member C, transcript variant X2
MGAT4 family member C, transcript variant X1
isoform 2 is encoded by transcript variant 7; Derived by automated computational analysis using gene prediction method: BestRefSeq.
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase isoform 2
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase isoform X2
isoform 1 precursor is encoded by transcript variant 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase isoform 1 precursor
propagated from UniProtKB/Swiss-Prot (Q9DGD1.1); transmembrane region
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q9DGD1.1); glycosylation site
isoform 1 precursor is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 1 precursor is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 1 precursor is encoded by transcript variant 5; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 1 precursor is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 1 precursor is encoded by transcript variant 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase isoform X1
transmembrane protein 183A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
transmembrane protein 183A, transcript variant X1
PTPRF interacting protein alpha 4, transcript variant X1
PTPRF interacting protein alpha 4, transcript variant X2
PTPRF interacting protein alpha 4, transcript variant X3
PTPRF interacting protein alpha 4, transcript variant X4
PTPRF interacting protein alpha 4, transcript variant X5
myogenin; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (P17920.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
adenosine A1 receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (P49892.1); transmembrane region
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P49892.1); glycosylation site
myosin binding protein H like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (Q05623.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
DENN domain containing 2D, transcript variant X2
DENN domain containing 2D, transcript variant X1
DENN domain-containing protein 2D isoform X1
DENN domain-containing protein 2D isoform X2
choline/ethanolamine phosphotransferase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
choline/ethanolamine phosphotransferase 1, transcript variant X2
choline/ethanolamine phosphotransferase 1, transcript variant X1
choline/ethanolamine phosphotransferase 1, transcript variant X4
choline/ethanolamine phosphotransferase 1, transcript variant X3
choline/ethanolamine phosphotransferase 1
choline/ethanolaminephosphotransferase 1
choline/ethanolaminephosphotransferase 1 isoform X2
choline/ethanolaminephosphotransferase 1 isoform X1
DNA damage regulated autophagy modulator 2, transcript variant X2
DNA damage regulated autophagy modulator 2, transcript variant X1
DNA damage-regulated autophagy modulator protein 2
ligand dependent nuclear receptor interacting factor 1, transcript variant X1
ligand-dependent nuclear receptor-interacting factor 1 isoform X1
cryptochrome 4; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001039596.1
The RefSeq transcript has 10 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001034685.1
The RefSeq protein has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ubiquitin conjugating enzyme E2 T, transcript variant X1
ubiquitin conjugating enzyme E2 T, transcript variant X5
ubiquitin conjugating enzyme E2 T, transcript variant X10
ubiquitin conjugating enzyme E2 T, transcript variant X4
ubiquitin conjugating enzyme E2 T, transcript variant X8
ubiquitin conjugating enzyme E2 T, transcript variant X3
ubiquitin conjugating enzyme E2 T, transcript variant X7
ubiquitin conjugating enzyme E2 T, transcript variant X2
ubiquitin conjugating enzyme E2 T, transcript variant X6
ubiquitin conjugating enzyme E2 T, transcript variant X9
ubiquitin-conjugating enzyme E2 T isoform X1
ubiquitin-conjugating enzyme E2 T isoform X2
tetraspanin-18-like, transcript variant X8
tetraspanin-18-like, transcript variant X11
tetraspanin-18-like, transcript variant X7
tetraspanin-18-like, transcript variant X6
tetraspanin-18-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X2
tetraspanin-18-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
leukocyte surface antigen CD53-like isoform X5
leukocyte surface antigen CD53-like isoform X3
uncharacterized protein LOC428541 isoform X2
leukocyte surface antigen CD53-like isoform X8
tetraspanin-18-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
adiponectin receptor 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
translocase of inner mitochondrial membrane 17 homolog B (yeast); Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
translocase of inner mitochondrial membrane 17 homolog B (yeast)
translocase of inner mitochondrial membrane 17 homolog B (yeast), transcript variant X1
translocase of inner mitochondrial membrane 17 homolog B (yeast), transcript variant X3
translocase of inner mitochondrial membrane 17 homolog B (yeast), transcript variant X2
translocase of inner mitochondrial membrane 17 homolog B (yeast), transcript variant X4
mitochondrial import inner membrane translocase subunit Tim17-A
mitochondrial import inner membrane translocase subunit Tim17-A isoform X2
mitochondrial import inner membrane translocase subunit Tim17-A isoform X1
myb-related transcription factor, partner of profilin-like, transcript variant X1
myb-related transcription factor, partner of profilin-like, transcript variant X2
myb-related transcription factor, partner of profilin-like isoform X1
myb-related transcription factor, partner of profilin-like isoform X2
innate immunity activator protein isoform X2
innate immunity activator protein isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
endosome-lysosome associated apoptosis and autophagy regulator 1
endosome/lysosome-associated apoptosis and autophagy regulator 1
seryl-tRNA synthetase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cadherin EGF LAG seven-pass G-type receptor 2
cadherin EGF LAG seven-pass G-type receptor 2 isoform X1
proline and serine rich coiled-coil 1, transcript variant X3
proline and serine rich coiled-coil 1, transcript variant X2
proline and serine rich coiled-coil 1, transcript variant X8
proline and serine rich coiled-coil 1, transcript variant X6
proline and serine rich coiled-coil 1, transcript variant X9
proline and serine rich coiled-coil 1, transcript variant X7
proline/serine-rich coiled-coil protein 1 isoform X3
proline/serine-rich coiled-coil protein 1 isoform X2
proline/serine-rich coiled-coil protein 1 isoform X6
proline/serine-rich coiled-coil protein 1 isoform X7
proline and serine rich coiled-coil 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
proline/serine-rich coiled-coil protein 1 isoform X5
proline/serine-rich coiled-coil protein 1 isoform X4
proline/serine-rich coiled-coil protein 1 isoform X1
proline/serine-rich coiled-coil protein 1 isoform X8
peptidylprolyl isomerase like 1, transcript variant X2
peptidylprolyl isomerase like 1, transcript variant X7
peptidylprolyl isomerase like 1, transcript variant X3
peptidylprolyl isomerase like 1, transcript variant X6
peptidylprolyl isomerase like 1, transcript variant X5
peptidylprolyl isomerase like 1, transcript variant X4
peptidylprolyl isomerase like 1, transcript variant X1
peptidyl-prolyl cis-trans isomerase-like 1 isoform X1
peptidyl-prolyl cis-trans isomerase-like 1 isoform X2
microRNA mir-12252; Derived by automated computational analysis using gene prediction method: BestRefSeq.
proteasome subunit alpha 5; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
proteasome subunit alpha 5, transcript variant X1
synaptophysin like 2, transcript variant X2
synaptophysin like 2, transcript variant X1
amphoterin-induced protein 1-like, transcript variant X1
G protein subunit alpha i3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
guanine nucleotide-binding protein G(i) subunit alpha-3
G protein subunit alpha i3, transcript variant X1
guanine nucleotide-binding protein G(i) subunit alpha-3 isoform X1
G protein subunit alpha transducin 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
G protein subunit alpha transducin 2, transcript variant X2
G protein subunit alpha transducin 2, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_204690.2
The RefSeq transcript has 4 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
guanine nucleotide-binding protein G(t) subunit alpha-2 isoform X1
guanine nucleotide-binding protein G(t) subunit alpha-2
adenosine monophosphate deaminase 2, transcript variant X1
adenosine monophosphate deaminase 2, transcript variant X2
glutathione S-transferase mu 2 (muscle); Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
glutathione S-transferase mu 2 (muscle), transcript variant X1
propagated from UniProtKB/Swiss-Prot (P20136.4); Region: Glutathione binding. /evidence=ECO:0000305|PubMed:10903867, ECO:0000305|PubMed:9571047
glutathione S-transferase 2-like, transcript variant X1
glutathione S-transferase 2-like isoform X1
epidermal growth factor receptor kinase substrate 8-like protein 3, transcript variant X3
epidermal growth factor receptor kinase substrate 8-like protein 3, transcript variant X2
epidermal growth factor receptor kinase substrate 8-like protein 3, transcript variant X1
epidermal growth factor receptor kinase substrate 8-like protein 3 isoform X3
epidermal growth factor receptor kinase substrate 8-like protein 3 isoform X2
epidermal growth factor receptor kinase substrate 8-like protein 3 isoform X1
colony stimulating factor 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
colony stimulating factor 1, transcript variant 1
colony stimulating factor 1, transcript variant 2
macrophage colony-stimulating factor 1 isoform 1 precursor
isoform 2 precursor is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
macrophage colony-stimulating factor 1 isoform 2 precursor
adenosylhomocysteinase like 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
adenosylhomocysteinase like 1, transcript variant 2
adenosylhomocysteinase like 1, transcript variant X10
adenosylhomocysteinase like 1, transcript variant X11
adenosylhomocysteinase like 1, transcript variant X3
adenosylhomocysteinase like 1, transcript variant X5
adenosylhomocysteinase like 1, transcript variant X2
adenosylhomocysteinase like 1, transcript variant X4
S-adenosylhomocysteine hydrolase-like protein 1
adenosylhomocysteinase like 1, transcript variant X1
S-adenosylhomocysteine hydrolase-like protein 1 isoform X1
adenosylhomocysteinase like 1, transcript variant X6
adenosylhomocysteinase like 1, transcript variant X7
S-adenosylhomocysteine hydrolase-like protein 1 isoform X2
adenosylhomocysteinase like 1, transcript variant X8
adenosylhomocysteinase like 1, transcript variant X9
S-adenosylhomocysteine hydrolase-like protein 1 isoform X3
striatin interacting protein 1, transcript variant X3
striatin interacting protein 1, transcript variant X1
striatin interacting protein 1, transcript variant X2
striatin-interacting protein 1 isoform X3
striatin-interacting protein 1 isoform X1
striatin-interacting protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 17% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 17, transcript variant X3
solute carrier family 6 member 17, transcript variant X7
solute carrier family 6 member 17, transcript variant X2
solute carrier family 6 member 17, transcript variant X4
solute carrier family 6 member 17, transcript variant X1
solute carrier family 6 member 17, transcript variant X11
solute carrier family 6 member 17, transcript variant X6
solute carrier family 6 member 17, transcript variant X10
solute carrier family 6 member 17, transcript variant X8
solute carrier family 6 member 17, transcript variant X5
solute carrier family 6 member 17, transcript variant X9
sodium-dependent neutral amino acid transporter SLC6A17
potassium voltage-gated channel, Shaw-related subfamily, member 4, transcript variant X3
potassium voltage-gated channel, Shaw-related subfamily, member 4, transcript variant X1
potassium voltage-gated channel, Shaw-related subfamily, member 4, transcript variant X2
potassium voltage-gated channel subfamily C member 4 isoform X2
potassium voltage-gated channel subfamily C member 4 isoform X1
uncharacterized LOC121107613, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC121107613, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC121107613, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
solute carrier family 16 member 4, transcript variant X2
solute carrier family 16 member 4, transcript variant X1
monocarboxylate transporter 5 isoform X2
monocarboxylate transporter 5 isoform X1
solute carrier family 16 member 4, transcript variant X3
uncharacterized LOC112530323, transcript variant X1
monocarboxylate transporter 5 isoform X3
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5; Derived by automated computational analysis using gene prediction method: BestRefSeq.
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
pepsinogen 3, group I (pepsinogen A); Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_205054.2
The RefSeq transcript has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P16476.1); glycosylation site
potassium voltage-gated channel subfamily A member 10; Derived by automated computational analysis using gene prediction method: BestRefSeq.
potassium voltage-gated channel subfamily A member 10, transcript variant 1
potassium voltage-gated channel subfamily A member 10, transcript variant 2
potassium voltage-gated channel subfamily A member 10
propagated from UniProtKB/Swiss-Prot (Q7T199.1); transmembrane region
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q7T199.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (Q7T199.1); Region: Selectivity filter. /evidence=ECO:0000250
potassium voltage-gated channel subfamily A member 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
potassium voltage-gated channel subfamily A member 2
potassium voltage-gated channel subfamily A member 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
potassium voltage-gated channel subfamily A member 3, transcript variant 2
potassium voltage-gated channel subfamily A member 3, transcript variant 1
potassium voltage-gated channel subfamily A member 3
omega-hydroxyceramide transacylase-like, transcript variant X1
omega-hydroxyceramide transacylase-like, transcript variant X2
omega-hydroxyceramide transacylase-like isoform X1
omega-hydroxyceramide transacylase-like isoform X2
patatin like phospholipase domain containing 1
chromosome 26 open reading frame, human C6orf222, transcript variant X2
chromosome 26 open reading frame, human C6orf222, transcript variant X1
apoptosis facilitator Bcl-2-like protein 14 isoform X2
apoptosis facilitator Bcl-2-like protein 14 isoform X1
potassium channel tetramerization domain containing 20, transcript variant X12
potassium channel tetramerization domain containing 20, transcript variant X13
potassium channel tetramerization domain containing 20, transcript variant X9
potassium channel tetramerization domain containing 20, transcript variant X11
potassium channel tetramerization domain containing 20, transcript variant X10
potassium channel tetramerization domain containing 20, transcript variant X16
potassium channel tetramerization domain containing 20, transcript variant X15
potassium channel tetramerization domain containing 20, transcript variant X5
potassium channel tetramerization domain containing 20, transcript variant X8
potassium channel tetramerization domain containing 20, transcript variant X2
potassium channel tetramerization domain containing 20, transcript variant X6
BTB/POZ domain-containing protein KCTD20 isoform X2
BTB/POZ domain-containing protein KCTD20 isoform X6
BTB/POZ domain-containing protein KCTD20 isoform X5
BTB/POZ domain-containing protein KCTD20 isoform X8
potassium channel tetramerization domain containing 20, transcript variant X14
potassium channel tetramerization domain containing 20, transcript variant X3
potassium channel tetramerization domain containing 20, transcript variant X7
BTB/POZ domain-containing protein KCTD20 isoform X3
BTB/POZ domain-containing protein KCTD20 isoform X7
potassium channel tetramerization domain containing 20, transcript variant X1
potassium channel tetramerization domain containing 20, transcript variant X4
BTB/POZ domain-containing protein KCTD20 isoform X1
BTB/POZ domain-containing protein KCTD20 isoform X4
BTB/POZ domain-containing protein KCTD20 isoform X9
BTB/POZ domain-containing protein KCTD20 isoform X10
serine/threonine kinase 38, transcript variant X1
serine/threonine kinase 38, transcript variant X3
serine/threonine kinase 38, transcript variant X2
serine/threonine-protein kinase 38 isoform X1
serine/threonine-protein kinase 38 isoform X2
serine and arginine rich splicing factor 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
serine and arginine rich splicing factor 3, transcript variant X1
serine and arginine rich splicing factor 3
serine/arginine-rich splicing factor 3 isoform X1
cyclin dependent kinase inhibitor 1A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
cyclin dependent kinase inhibitor 1A, transcript variant X1
cyclin dependent kinase inhibitor 1A, transcript variant X2
cyclin dependent kinase inhibitor 1A, transcript variant 2
cyclin dependent kinase inhibitor 1A, transcript variant 1
isoform 2 is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cyclin-dependent kinase inhibitor 1 isoform 2
isoform 1 is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cyclin-dependent kinase inhibitor 1 isoform 1
cyclin-dependent kinase inhibitor 1 isoform X1
RAB44, member RAS oncogene family, transcript variant X1
RAB44, member RAS oncogene family, transcript variant X5
RAB44, member RAS oncogene family, transcript variant X3
RAB44, member RAS oncogene family, transcript variant X6
RAB44, member RAS oncogene family, transcript variant X4
RAB44, member RAS oncogene family, transcript variant X2
C6orf89 homolog; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
bombesin receptor-activated protein C6orf89 homolog isoform X1
bombesin receptor-activated protein C6orf89 homolog
bombesin receptor-activated protein C6orf89 homolog isoform X2
peptidase inhibitor 16, transcript variant X3
peptidase inhibitor 16, transcript variant X10
peptidase inhibitor 16, transcript variant X4
peptidase inhibitor 16, transcript variant X6
peptidase inhibitor 16, transcript variant X5
peptidase inhibitor 16, transcript variant X7
peptidase inhibitor 16, transcript variant X1
peptidase inhibitor 16, transcript variant X2
peptidase inhibitor 16, transcript variant X8
peptidase inhibitor 16, transcript variant X9
mitochondrial carrier 1, transcript variant X3
mitochondrial carrier 1, transcript variant X1
mitochondrial carrier 1, transcript variant X2
microRNA let-7e; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA let-7a-1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
mitochondrial carrier 1, transcript variant X5
mitochondrial carrier 1, transcript variant X4
mitochondrial carrier homolog 1 isoform X1
mitochondrial carrier homolog 1 isoform X3
mitochondrial carrier homolog 1 isoform X2
small nuclear ribonucleoprotein polypeptide E; Derived by automated computational analysis using gene prediction method: BestRefSeq.
small nuclear ribonucleoprotein polypeptide E
ethanolamine kinase 2, transcript variant X1
ethanolamine kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X27
pleckstrin homology domain containing A6, transcript variant X14
pleckstrin homology domain containing A6, transcript variant X26
pleckstrin homology domain containing A6, transcript variant X11
pleckstrin homology domain containing A6, transcript variant X25
pleckstrin homology domain containing A6, transcript variant X7
pleckstrin homology domain containing A6, transcript variant X4
pleckstrin homology domain containing A6, transcript variant X15
pleckstrin homology domain containing A6, transcript variant X13
pleckstrin homology domain containing A6, transcript variant X9
pleckstrin homology domain containing A6, transcript variant X8
pleckstrin homology domain containing A6, transcript variant X12
pleckstrin homology domain containing A6, transcript variant X3
pleckstrin homology domain containing A6, transcript variant X6
pleckstrin homology domain containing A6, transcript variant X10
pleckstrin homology domain containing A6, transcript variant X5
pleckstrin homology domain containing A6, transcript variant X1
pleckstrin homology domain containing A6, transcript variant X20
pleckstrin homology domain containing A6, transcript variant X2
pleckstrin homology domain containing A6, transcript variant X19
pleckstrin homology domain containing A6, transcript variant X18
pleckstrin homology domain containing A6, transcript variant X17
pleckstrin homology domain containing A6, transcript variant X21
pleckstrin homology domain containing A6, transcript variant X22
pleckstrin homology domain containing A6, transcript variant X16
pleckstrin homology domain containing A6, transcript variant X24
pleckstrin homology domain containing A6, transcript variant X23
pleckstrin homology domain-containing family A member 6 isoform X5
pleckstrin homology domain-containing family A member 6 isoform X20
pleckstrin homology domain-containing family A member 6 isoform X14
pleckstrin homology domain-containing family A member 6 isoform X2
pleckstrin homology domain-containing family A member 6 isoform X16
pleckstrin homology domain-containing family A member 6 isoform X19
pleckstrin homology domain-containing family A member 6 isoform X11
pleckstrin homology domain-containing family A member 6 isoform X18
pleckstrin homology domain-containing family A member 6 isoform X7
pleckstrin homology domain-containing family A member 6 isoform X4
pleckstrin homology domain-containing family A member 6 isoform X15
pleckstrin homology domain-containing family A member 6 isoform X13
pleckstrin homology domain-containing family A member 6 isoform X9
pleckstrin homology domain-containing family A member 6 isoform X8
pleckstrin homology domain-containing family A member 6 isoform X12
pleckstrin homology domain-containing family A member 6 isoform X3
pleckstrin homology domain-containing family A member 6 isoform X6
pleckstrin homology domain-containing family A member 6 isoform X10
pleckstrin homology domain-containing family A member 6 isoform X1
pleckstrin homology domain-containing family A member 6 isoform X17
microRNA 6618; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC107055203, transcript variant X2
uncharacterized LOC107055203, transcript variant X1
protein phosphatase 1 regulatory subunit 15B
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X1
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X2
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X6
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X4
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X3
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X5
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X7
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
MDM4, p53 regulator, transcript variant X6
MDM4, p53 regulator, transcript variant X4
MDM4, p53 regulator, transcript variant X5
MDM4, p53 regulator, transcript variant X2
MDM4, p53 regulator, transcript variant X1
MDM4, p53 regulator, transcript variant X3
leucine rich repeat neuronal 2, transcript variant X1
leucine rich repeat neuronal 2, transcript variant X2
neurofascin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (O42414.1); glycosylation site
Cleavage. /evidence=ECO:0000305|PubMed:1377696; propagated from UniProtKB/Swiss-Prot (O42414.1); cleavage site
propagated from UniProtKB/Swiss-Prot (O42414.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
isoform 6 precursor is encoded by transcript variant 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 3 precursor is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 5 precursor is encoded by transcript variant 5; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 8 precursor is encoded by transcript variant 8; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 7 precursor is encoded by transcript variant 7; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 4 precursor is encoded by transcript variant 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
contactin 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P28685.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P28685.1); Region: Hinge. /evidence=ECO:0000255
propagated from UniProtKB/Swiss-Prot (P28685.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
transmembrane protein 81, transcript variant X2
transmembrane protein 81, transcript variant X1
RB binding protein 5, histone lysine methyltransferase complex subunit; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X2
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X3
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X5
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X4
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X1
RB binding protein 5, histone lysine methyltransferase complex subunit
retinoblastoma-binding protein 5 isoform X4
retinoblastoma-binding protein 5 isoform X3
retinoblastoma-binding protein 5 isoform X1
retinoblastoma-binding protein 5 isoform X2
dual serine/threonine and tyrosine protein kinase; Derived by automated computational analysis using gene prediction method: BestRefSeq.
dual serine/threonine and tyrosine protein kinase
transmembrane and coiled-coil domain family 2, transcript variant X1
transmembrane and coiled-coil domains protein 2 isoform X1
transmembrane and coiled-coil domain family 2, transcript variant X2
transmembrane and coiled-coil domain family 2, transcript variant X4
transmembrane and coiled-coil domain family 2, transcript variant X5
transmembrane and coiled-coil domain family 2, transcript variant X3
transmembrane and coiled-coil domains protein 2 isoform X2
transmembrane and coiled-coil domains protein 2 isoform X3
kelch domain containing 8A, transcript variant X2
kelch domain containing 8A, transcript variant X3
kelch domain containing 8A, transcript variant X1
kelch domain containing 8A, transcript variant X4
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
BLACAT1 overlapping LEMD1 locus, transcript variant X2
BLACAT1 overlapping LEMD1 locus, transcript variant X3
BLACAT1 overlapping LEMD1 locus, transcript variant X5
BLACAT1 overlapping LEMD1 locus, transcript variant X4
BLACAT1 overlapping LEMD1 locus, transcript variant X1
bladder cancer associated transcript 1 isoform X2
bladder cancer associated transcript 1 isoform X5
bladder cancer associated transcript 1 isoform X4
bladder cancer associated transcript 1 isoform X1
bladder cancer associated transcript 1 isoform X3
BLACAT1 overlapping LEMD1 locus, transcript variant X6
microRNA 135a-3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
bladder cancer associated transcript 1 isoform X6
cyclin dependent kinase 18, transcript variant X2
cyclin dependent kinase 18, transcript variant X3
cyclin dependent kinase 18, transcript variant X1
major facilitator superfamily domain containing 4A
major facilitator superfamily domain-containing protein 4A
ELK4, ETS transcription factor, transcript variant X2
ELK4, ETS transcription factor, transcript variant X1
Krueppel-like factor 15, transcript variant X18
Krueppel-like factor 15, transcript variant X8
Krueppel-like factor 15, transcript variant X7
Krueppel-like factor 15, transcript variant X14
Krueppel-like factor 15, transcript variant X13
Krueppel-like factor 15, transcript variant X12
Krueppel-like factor 15, transcript variant X11
Krueppel-like factor 15, transcript variant X10
Krueppel-like factor 15, transcript variant X15
Krueppel-like factor 15, transcript variant X5
Krueppel-like factor 15, transcript variant X4
Krueppel-like factor 15, transcript variant X17
Krueppel-like factor 15, transcript variant X2
Krueppel-like factor 15, transcript variant X1
Krueppel-like factor 15, transcript variant X9
Krueppel-like factor 15, transcript variant X3
Krueppel-like factor 15, transcript variant X16
Krueppel-like factor 15, transcript variant X6
solute carrier family 45 member 3, transcript variant X10
solute carrier family 45 member 3, transcript variant X6
solute carrier family 45 member 3, transcript variant X5
solute carrier family 45 member 3, transcript variant X4
solute carrier family 45 member 3, transcript variant X11
solute carrier family 45 member 3, transcript variant X13
solute carrier family 45 member 3, transcript variant X7
solute carrier family 45 member 3, transcript variant X9
solute carrier family 45 member 3, transcript variant X3
solute carrier family 45 member 3, transcript variant X8
solute carrier family 45 member 3, transcript variant X12
solute carrier family 45 member 3, transcript variant X2
solute carrier family 45 member 3, transcript variant X1
nuclear casein kinase and cyclin dependent kinase substrate 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
nuclear casein kinase and cyclin dependent kinase substrate 1
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1
RAB7, member RAS oncogene family-like 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 1797; Derived by automated computational analysis using gene prediction method: BestRefSeq.
solute carrier family 41 member 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 6602; Derived by automated computational analysis using gene prediction method: BestRefSeq.
peptidase M20 domain containing 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
peptidase M20 domain containing 1, transcript variant X6
peptidase M20 domain containing 1, transcript variant X3
peptidase M20 domain containing 1, transcript variant X5
peptidase M20 domain containing 1, transcript variant X4
peptidase M20 domain containing 1, transcript variant X2
peptidase M20 domain containing 1, transcript variant X1
peptidase M20 domain containing 1, transcript variant 2
peptidase M20 domain containing 1, transcript variant 1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X2
N-fatty-acyl-amino acid synthase/hydrolase PM20D1 precursor
/evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q5ZL18.1)
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q5ZL18.1); glycosylation site
N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X3
solute carrier family 26 member 9, transcript variant X1
solute carrier family 26 member 9, transcript variant X2
chromosome 1 open reading frame 186, transcript variant X1
chromosome 1 open reading frame 186, transcript variant X7
chromosome 1 open reading frame 186, transcript variant X5
chromosome 1 open reading frame 186, transcript variant X6
regulator of hemoglobinization and erythroid cell expansion protein isoform X2
RAB7B, member RAS oncogene family, transcript variant X1
uncharacterized LOC419840; Derived by automated computational analysis using gene prediction method: BestRefSeq.
chromosome 1 open reading frame 186, transcript variant X2
chromosome 1 open reading frame 186, transcript variant X3
chromosome 1 open reading frame 186, transcript variant X4
chromosome 1 open reading frame 186, transcript variant X8
regulator of hemoglobinization and erythroid cell expansion protein isoform X1
regulator of hemoglobinization and erythroid cell expansion protein isoform X3
arginine vasopressin receptor 1B; Derived by automated computational analysis using gene prediction method: BestRefSeq.
family with sequence similarity 72 member A, transcript variant X2
family with sequence similarity 72 member A, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X6
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X3
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X5
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X4
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X10
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X12
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X11
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X13
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X7
SLIT-ROBO Rho GTPase-activating protein 2 isoform X3
SLIT-ROBO Rho GTPase-activating protein 2 isoform X4
SLIT-ROBO Rho GTPase-activating protein 2 isoform X9
SLIT-ROBO Rho GTPase-activating protein 2 isoform X10
SLIT-ROBO Rho GTPase-activating protein 2 isoform X5
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X2
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X8
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X9
SLIT-ROBO Rho GTPase-activating protein 2 isoform X1
SLIT-ROBO Rho GTPase-activating protein 2 isoform X2
SLIT-ROBO Rho GTPase-activating protein 2 isoform X7
SLIT-ROBO Rho GTPase-activating protein 2 isoform X8
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X14
SLIT-ROBO Rho GTPase-activating protein 2 isoform X11
SLIT-ROBO Rho GTPase-activating protein 2 isoform X6
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X1
inhibitor of nuclear factor kappa-B kinase subunit epsilon
Ras association domain family member 5; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Ras association domain family member 5, transcript variant X2
Ras association domain family member 5, transcript variant X1
ras association domain-containing protein 5 isoform X1
ras association domain-containing protein 5 isoform X2
Ras association domain family member 5, transcript variant X3
ras association domain-containing protein 5 isoform X3
Ras association domain family member 5, transcript variant X4
ras association domain-containing protein 5
ras association domain-containing protein 5 isoform X4
eukaryotic translation initiation factor 2D; Derived by automated computational analysis using gene prediction method: BestRefSeq.
eukaryotic translation initiation factor 2D
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X2
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X1
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X1
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X4
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X3
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X2
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X3
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X5
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X4
interleukin 10; Derived by automated computational analysis using gene prediction method: BestRefSeq.
polymeric immunoglobulin receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq.
polymeric immunoglobulin receptor precursor
uncharacterized LOC107055195, transcript variant X1
Fc fragment of IgA and IgM receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor
specifically androgen-regulated gene protein
uncharacterized LOC107055195, transcript variant X2
YOD1 deubiquitinase; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (Q5F3A6.1); Region: UBX-like
propagated from UniProtKB/Swiss-Prot (Q5F3A6.1); Region: Cys-loop. /evidence=ECO:0000250|UniProtKB:Q5VVQ6
propagated from UniProtKB/Swiss-Prot (Q5F3A6.1); Region: Variable-loop. /evidence=ECO:0000250|UniProtKB:Q5VVQ6
propagated from UniProtKB/Swiss-Prot (Q5F3A6.1); Region: His-loop. /evidence=ECO:0000250|UniProtKB:Q5VVQ6
propagated from UniProtKB/Swiss-Prot (Q5F3A6.1); Region: S2 site. /evidence=ECO:0000250|UniProtKB:Q5VVQ6
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X5
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X7
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X6
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X8
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X10
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X9
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X11
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X8
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X11
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X6
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X9
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X7
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X10
complement component 4 binding protein, secretory; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
complement component 4 binding protein, secretory, transcript variant X1
complement component 4 binding protein, secretory, transcript variant X2
complement component 4 binding protein, secretory, transcript variant X3
complement component 4 binding protein, secretory, transcript variant X4
complement component 4 binding protein, secretory
C4b-binding protein alpha chain precursor
C4b-binding protein alpha chain isoform X1
C4b-binding protein alpha chain isoform X2
C4b-binding protein alpha chain isoform X3
complement decay-accelerating factor-like, transcript variant X1
complement decay-accelerating factor-like, transcript variant X2
complement decay-accelerating factor-like isoform X2
complement decay-accelerating factor-like isoform X1
CD55 molecule (Cromer blood group), transcript variant X2
complement decay-accelerating factor isoform X2
CD55 molecule (Cromer blood group), transcript variant X1
complement decay-accelerating factor isoform X1
complement component 4 binding protein, GPI-anchored; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
complement component 4 binding protein, GPI-anchored, transcript variant X1
complement component 4 binding protein, GPI-anchored isoform X1
complement component 4 binding protein, GPI-anchored
similar to RNA sequence, mRNA (same species):RefSeq:NM_001033643.1
The RefSeq transcript has 7 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001028815.1
complement component 4 binding protein, GPI-anchored precursor
complement component (3d/Epstein Barr virus) receptor 2
complement component 4 binding protein, membrane; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
complement component 4 binding protein, membrane, transcript variant X4
complement component 4 binding protein, membrane, transcript variant X5
complement component 4 binding protein, membrane, transcript variant X2
complement component 4 binding protein, membrane, transcript variant X3
complement component 4 binding protein, membrane, transcript variant X11
complement component 4 binding protein, membrane, transcript variant X10
complement component 4 binding protein, membrane, transcript variant X13
complement component 4 binding protein, membrane, transcript variant X14
complement component 4 binding protein, membrane, transcript variant X15
complement component 4 binding protein, membrane, transcript variant X12
complement component 4 binding protein, membrane, transcript variant X16
complement component 4 binding protein, membrane, transcript variant X17
complement component 4 binding protein, membrane, transcript variant X7
complement component 4 binding protein, membrane, transcript variant X9
complement component 4 binding protein, membrane, transcript variant X8
complement component 4 binding protein, membrane, transcript variant X6
complement component 4 binding protein, membrane, transcript variant X1
complement component 4 binding protein, membrane
similar to RNA sequence, mRNA (same species):RefSeq:NM_204664.2
The RefSeq transcript has 11 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_989995.1
The RefSeq protein has 5 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
complement component 4 binding protein, alpha chain precursor
complement component 4 binding protein, alpha chain isoform X4
complement component 4 binding protein, alpha chain isoform X1
complement component 4 binding protein, alpha chain isoform X3
complement component 4 binding protein, alpha chain isoform X5
complement component 4 binding protein, alpha chain isoform X2
microRNA 29c; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 29b-2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC112530321, transcript variant X1
hematopoietic progenitor cell antigen CD34 isoform X2
hematopoietic progenitor cell antigen CD34 isoform X1
hematopoietic progenitor cell antigen CD34 isoform X4
hematopoietic progenitor cell antigen CD34 isoform X3
microRNA 6654; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 205; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA mir-205c; Derived by automated computational analysis using gene prediction method: BestRefSeq.
calcium/calmodulin-dependent protein kinase IG, transcript variant X2
calcium/calmodulin-dependent protein kinase IG, transcript variant X3
calcium/calmodulin-dependent protein kinase IG, transcript variant X1
calcium/calmodulin-dependent protein kinase type 1G
laminin subunit beta 3, transcript variant X2
laminin subunit beta 3, transcript variant X1
G0/G1 switch 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
hydroxysteroid 11-beta dehydrogenase 1A, transcript variant X1
hydroxysteroid 11-beta dehydrogenase 1A, transcript variant X3
hydroxysteroid 11-beta dehydrogenase 1A, transcript variant X2
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X1
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X3
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X2
corticosteroid 11-beta-dehydrogenase isozyme 1
TRAF3 interacting protein 3, transcript variant X5
TRAF3 interacting protein 3, transcript variant X1
TRAF3 interacting protein 3, transcript variant X7
TRAF3 interacting protein 3, transcript variant X11
TRAF3 interacting protein 3, transcript variant X15
TRAF3 interacting protein 3, transcript variant X4
TRAF3 interacting protein 3, transcript variant X8
TRAF3 interacting protein 3, transcript variant X12
TRAF3 interacting protein 3, transcript variant X13
TRAF3 interacting protein 3, transcript variant X2
TRAF3 interacting protein 3, transcript variant X6
TRAF3 interacting protein 3, transcript variant X10
TRAF3 interacting protein 3, transcript variant X14
TRAF3 interacting protein 3, transcript variant X3
TRAF3 interacting protein 3, transcript variant X9
TRAF3 interacting protein 3, transcript variant X16
TRAF3 interacting protein 3, transcript variant X17
TRAF3 interacting protein 3, transcript variant X19
TRAF3 interacting protein 3, transcript variant X21
TRAF3 interacting protein 3, transcript variant X18
TRAF3 interacting protein 3, transcript variant X20
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3-interacting JNK-activating modulator isoform X3
TRAF3-interacting JNK-activating modulator isoform X4
TRAF3-interacting JNK-activating modulator isoform X6
TRAF3-interacting JNK-activating modulator isoform X2
TRAF3-interacting JNK-activating modulator isoform X7
TRAF3-interacting JNK-activating modulator isoform X8
TRAF3-interacting JNK-activating modulator isoform X5
TRAF3 interacting protein 3, transcript variant X22
TRAF3-interacting JNK-activating modulator isoform X9
interferon regulatory factor 6, transcript variant X2
interferon regulatory factor 6, transcript variant X1
interferon regulatory factor 6, transcript variant X7
interferon regulatory factor 6, transcript variant X3
interferon regulatory factor 6, transcript variant X6
interferon regulatory factor 6, transcript variant X5
interferon regulatory factor 6, transcript variant X4
interferon regulatory factor 6, transcript variant X8
interferon regulatory factor 6 isoform X2
interferon regulatory factor 6 isoform X1
interferon regulatory factor 6 isoform X4
interferon regulatory factor 6 isoform X3
interferon regulatory factor 6 isoform X5
guanylate cyclase activator 1B; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001007881.2
The RefSeq transcript has 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
guanylate cyclase activator 1A; Derived by automated computational analysis using gene prediction method: BestRefSeq.
putative uncharacterized protein GUCA1ANB isoform X2
putative uncharacterized protein GUCA1ANB isoform X1
putative uncharacterized protein GUCA1ANB isoform X3
chromosome 6 open reading frame 132, transcript variant X2
uncharacterized protein C6orf132 homolog isoform X2
chromosome 6 open reading frame 132, transcript variant X1
uncharacterized protein C6orf132 homolog isoform X1
endogenous retrovirus group K member 8 Gag polyprotein-like
endogenous retrovirus group K member 8 Gag polyprotein
WD repeat domain 77; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001030916.1
The RefSeq transcript has 2 substitutions, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ATP synthase peripheral stalk-membrane subunit b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ATP synthase F(0) complex subunit B1, mitochondrial
uncharacterized LOC121107627, transcript variant X3
uncharacterized LOC121107627, transcript variant X2
uncharacterized LOC121107627, transcript variant X1
adenosine A3 receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq.
RAP1A, member of RAS oncogene family, transcript variant X2
RAP1A, member of RAS oncogene family, transcript variant X1
RAP1A, member of RAS oncogene family, transcript variant X3
family with sequence similarity 212, member B
DEAD-box helicase 20, transcript variant X1
DEAD-box helicase 20, transcript variant X2
probable ATP-dependent RNA helicase DDX20 isoform X1
probable ATP-dependent RNA helicase DDX20 isoform X2
potassium voltage-gated channel subfamily D member 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
potassium voltage-gated channel subfamily D member 3, transcript variant X1
potassium voltage-gated channel subfamily D member 3, transcript variant X2
potassium voltage-gated channel subfamily D member 3, transcript variant X4
potassium voltage-gated channel subfamily D member 3, transcript variant X3
potassium voltage-gated channel subfamily D member 3, transcript variant X5
potassium voltage-gated channel subfamily D member 3
potassium voltage-gated channel subfamily D member 3 isoform X2
potassium voltage-gated channel subfamily D member 3 precursor
potassium voltage-gated channel subfamily D member 3 isoform X1
CTTNBP2 N-terminal like, transcript variant X2
CTTNBP2 N-terminal like, transcript variant X3
CTTNBP2 N-terminal like, transcript variant X1
CTTNBP2 N-terminal-like protein isoform X1
CTTNBP2 N-terminal-like protein isoform X2
translation initiation factor IF-2-like isoform X1
Wnt family member 2B; Derived by automated computational analysis using gene prediction method: BestRefSeq.
/evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q98SN7.1)
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q98SN7.1); glycosylation site
suppression of tumorigenicity 7 like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
suppression of tumorigenicity 7 like, transcript variant 2
suppression of tumorigenicity 7 like, transcript variant 1
suppression of tumorigenicity 7 like, transcript variant X2
suppressor of tumorigenicity 7 protein-like isoform 2
suppressor of tumorigenicity 7 protein-like isoform X2
suppressor of tumorigenicity 7 protein-like isoform 1
suppression of tumorigenicity 7 like, transcript variant X1
suppressor of tumorigenicity 7 protein-like isoform X1
capping actin protein of muscle Z-line alpha subunit 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
capping actin protein of muscle Z-line alpha subunit 1
Mov10 RISC complex RNA helicase; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Mov10 RISC complex RNA helicase, transcript variant X1
propagated from UniProtKB/Swiss-Prot (Q5ZKD7.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (Q5ZKD7.1); Region: DEAG box
ras homolog family member C; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ras homolog family member C, transcript variant X1
rho-related GTP-binding protein RhoC isoform X1
propagated from UniProtKB/Swiss-Prot (Q9PSX7.1); Region: Effector region. /evidence=ECO:0000255
Cysteine methyl ester. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q9PSX7.1); methylation site
protein phosphatase, Mg2+/Mn2+ dependent 1J, transcript variant X2
protein phosphatase, Mg2+/Mn2+ dependent 1J, transcript variant X1
family with sequence similarity 19 member A3, C-C motif chemokine like, transcript variant X1
family with sequence similarity 19 member A3, C-C motif chemokine like, transcript variant X2
solute carrier family 16 member 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
solute carrier family 16 member 1, transcript variant X2
solute carrier family 16 member 1, transcript variant X1
monocarboxylate transporter 1 isoform X1
microRNA 1669; Derived by automated computational analysis using gene prediction method: BestRefSeq.
leucine rich repeats and immunoglobulin like domains 2, transcript variant X1
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X1
leucine rich repeats and immunoglobulin like domains 2, transcript variant X2
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X2
membrane associated guanylate kinase, WW and PDZ domain containing 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant 2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001012697.1
The RefSeq transcript has 22 substitutions, 3 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant 1
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform 1
propagated from UniProtKB/Swiss-Prot (Q5F488.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X1
similar to AA sequence (same species):RefSeq:NP_001012715.1
isoform 2 is encoded by transcript variant 2; The RefSeq protein has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform 2
putative homeodomain transcription factor 1, transcript variant X4
putative homeodomain transcription factor 1, transcript variant X2
putative homeodomain transcription factor 1, transcript variant X3
putative homeodomain transcription factor 1, transcript variant X1
round spermatid basic protein 1 like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001389642.2
The RefSeq transcript has 5 substitutions, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001376571.2
The RefSeq protein has 1 substitution, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
protein tyrosine phosphatase, non-receptor type 22, transcript variant X1
tyrosine-protein phosphatase non-receptor type 22
adaptor related protein complex 4 beta 1 subunit; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
adaptor related protein complex 4 beta 1 subunit, transcript variant X1
adaptor related protein complex 4 beta 1 subunit
adaptor related protein complex 4 beta 1 subunit, transcript variant X2
DNA cross-link repair 1B; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001031500.3
The RefSeq transcript has 22 substitutions, 1 frameshift, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001026671.3
The RefSeq protein has 6 substitutions, 1 frameshift compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
homeodomain interacting protein kinase 1, transcript variant X1
homeodomain interacting protein kinase 1, transcript variant X2
homeodomain interacting protein kinase 1, transcript variant X3
homeodomain interacting protein kinase 1, transcript variant X4
homeodomain-interacting protein kinase 1 isoform X1
homeodomain-interacting protein kinase 1 isoform X2
homeodomain-interacting protein kinase 1 isoform X3
homeodomain-interacting protein kinase 1 isoform X4
olfactomedin like 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q25C36.1); glycosylation site
tripartite motif containing 33; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
tripartite motif containing 33, transcript variant X3
tripartite motif containing 33, transcript variant X2
tripartite motif containing 33, transcript variant X1
E3 ubiquitin-protein ligase TRIM33 isoform X3
E3 ubiquitin-protein ligase TRIM33 isoform X2
E3 ubiquitin-protein ligase TRIM33 isoform X1
breast carcinoma amplified sequence 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
DENN domain containing 2C; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
DENN domain containing 2C, transcript variant X5
DENN domain containing 2C, transcript variant X4
DENN domain containing 2C, transcript variant X3
DENN domain containing 2C, transcript variant X6
DENN domain containing 2C, transcript variant X7
DENN domain containing 2C, transcript variant X2
DENN domain containing 2C, transcript variant X1
DENN domain-containing protein 2C isoform X2
DENN domain-containing protein 2C isoform X1
DENN domain-containing protein 2C isoform X3
DENN domain containing 2C, transcript variant X8
adenosine monophosphate deaminase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
adenosine monophosphate deaminase 1, transcript variant X3
adenosine monophosphate deaminase 1, transcript variant X2
adenosine monophosphate deaminase 1, transcript variant X1
neuroblastoma RAS viral oncogene homolog; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
neuroblastoma RAS viral oncogene homolog
neuroblastoma RAS viral oncogene homolog, transcript variant X1
propagated from UniProtKB/Swiss-Prot (Q5F352.1); Region: Effector region
propagated from UniProtKB/Swiss-Prot (Q5F352.1); Region: Hypervariable region. /evidence=ECO:0000250
cold shock domain containing E1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cold shock domain containing E1, transcript variant 2
cold shock domain containing E1, transcript variant 1
cold shock domain-containing protein E1 isoform 2
cold shock domain-containing protein E1 isoform 1
suppressor of IKBKE 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
bile acid receptor-like, transcript variant X2
bile acid receptor-like, transcript variant X1
synaptonemal complex protein 1, transcript variant X1
synaptonemal complex protein 1, transcript variant X2
synaptonemal complex protein 1 isoform X1
synaptonemal complex protein 1 isoform X2
thyroid stimulating hormone beta; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
thyroid stimulating hormone beta, transcript variant X2
thyroid stimulating hormone beta, transcript variant X1
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (O57340.1); glycosylation site
nerve growth factor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
nerve growth factor, transcript variant 2
nerve growth factor, transcript variant X2
nerve growth factor, transcript variant X1
nerve growth factor, transcript variant 1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001293108.1
The RefSeq transcript has 7 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC101747934, transcript variant X8
uncharacterized LOC101747934, transcript variant X9
uncharacterized LOC101747934, transcript variant X2
uncharacterized LOC101747934, transcript variant X3
uncharacterized LOC101747934, transcript variant X1
uncharacterized LOC101747934, transcript variant X7
uncharacterized LOC101747934, transcript variant X5
uncharacterized LOC101747934, transcript variant X4
uncharacterized LOC101747934, transcript variant X10
uncharacterized LOC101747934, transcript variant X12
uncharacterized LOC101747934, transcript variant X11
uncharacterized LOC101747934, transcript variant X6
uncharacterized LOC101747934, transcript variant X13
Fanconi anemia complementation group E, transcript variant X1
Fanconi anemia complementation group E, transcript variant X2
Fanconi anemia group E protein isoform X1
Fanconi anemia group E protein isoform X2
makorin ring finger protein 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
peroxisome proliferator activated receptor delta; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
peroxisome proliferator activated receptor delta, transcript variant X14
peroxisome proliferator activated receptor delta, transcript variant X18
peroxisome proliferator activated receptor delta, transcript variant X7
peroxisome proliferator activated receptor delta, transcript variant X20
peroxisome proliferator activated receptor delta, transcript variant X2
peroxisome proliferator activated receptor delta, transcript variant X16
peroxisome proliferator activated receptor delta, transcript variant X3
peroxisome proliferator activated receptor delta, transcript variant X19
peroxisome proliferator activated receptor delta, transcript variant X6
peroxisome proliferator activated receptor delta, transcript variant X5
peroxisome proliferator activated receptor delta, transcript variant X15
peroxisome proliferator activated receptor delta, transcript variant X9
peroxisome proliferator activated receptor delta, transcript variant X8
peroxisome proliferator activated receptor delta, transcript variant X4
peroxisome proliferator activated receptor delta, transcript variant X17
peroxisome proliferator activated receptor delta, transcript variant X1
peroxisome proliferator activated receptor delta, transcript variant X10
peroxisome proliferator activated receptor delta, transcript variant X13
peroxisome proliferator activated receptor delta, transcript variant X12
peroxisome proliferator activated receptor delta
peroxisome proliferator activated receptor delta, transcript variant X11
peroxisome proliferator-activated receptor delta isoform X2
peroxisome proliferator-activated receptor delta isoform X1
peroxisome proliferator-activated receptor delta
DEF6, guanine nucleotide exchange factor, transcript variant X2
DEF6, guanine nucleotide exchange factor, transcript variant X1
differentially expressed in FDCP 6 homolog isoform X2
differentially expressed in FDCP 6 homolog isoform X1
zinc finger protein 76, transcript variant X7
zinc finger protein 76, transcript variant X4
zinc finger protein 76, transcript variant X5
zinc finger protein 76, transcript variant X6
zinc finger protein 76, transcript variant X3
zinc finger protein 76, transcript variant X1
zinc finger protein 76, transcript variant X2
ribosomal protein L10a, transcript variant X1
ribosomal protein L10a, transcript variant X2
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X7
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X6
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X5
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X4
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X3
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X2
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X1
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X5
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X7
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X6
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X4
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X3
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X2
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X9
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X4
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X6
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X5
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X3
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X7
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X8
ankyrin repeat and SAM domain-containing protein 1A isoform X5
ankyrin repeat and SAM domain-containing protein 1A isoform X2
ankyrin repeat and SAM domain-containing protein 1A isoform X8
ankyrin repeat and SAM domain-containing protein 1A isoform X3
ankyrin repeat and SAM domain-containing protein 1A isoform X4
ankyrin repeat and SAM domain-containing protein 1A isoform X1
ankyrin repeat and SAM domain-containing protein 1A isoform X6
ankyrin repeat and SAM domain-containing protein 1A isoform X7
TATA-box binding protein associated factor 11; Derived by automated computational analysis using gene prediction method: BestRefSeq.
TATA-box binding protein associated factor 11
transcription initiation factor TFIID subunit 11
UHRF1 binding protein 1, transcript variant X1
UHRF1 binding protein 1, transcript variant X2
UHRF1 binding protein 1, transcript variant X3
small nuclear ribonucleoprotein polypeptide C; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
small nuclear ribonucleoprotein polypeptide C
small nuclear ribonucleoprotein polypeptide C, transcript variant X1
propagated from UniProtKB/Swiss-Prot (E1C6F0.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
U1 small nuclear ribonucleoprotein C isoform X1
C6orf106 homolog; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
propagated from UniProtKB/Swiss-Prot (Q5F3N9.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
SAM pointed domain containing ETS transcription factor
SAM pointed domain-containing Ets transcription factor
protein kinase C and casein kinase substrate in neurons 1, transcript variant X2
protein kinase C and casein kinase substrate in neurons 1, transcript variant X1
protein kinase C and casein kinase substrate in neurons 1, transcript variant X3
protein kinase C and casein kinase substrate in neurons protein 1
ribosomal protein S10; Derived by automated computational analysis using gene prediction method: BestRefSeq.
nudix hydrolase 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
diphosphoinositol polyphosphate phosphohydrolase 1
uncharacterized LOC100858737, transcript variant X2
uncharacterized LOC100858737, transcript variant X1
high mobility group AT-hook 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
high mobility group AT-hook 1, transcript variant X1
high mobility group AT-hook 1, transcript variant X4
high mobility group AT-hook 1, transcript variant X5
high mobility group AT-hook 1, transcript variant 2
high mobility group AT-hook 1, transcript variant 1
high mobility group AT-hook 1, transcript variant X3
high mobility group AT-hook 1, transcript variant X2
high mobility group protein HMG-I/HMG-Y isoform X2
high mobility group protein HMG-I/HMG-Y isoform X1
uncharacterized LOC121107633, transcript variant X1
opsin, green sensitive (rhodopsin-like); Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_205490.1
The RefSeq transcript has 23 substitutions, 6 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P28683.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P28683.1); transmembrane region
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 long SRA read, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
motilin; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC121107635, transcript variant X1
chromosome 26 open reading frame, human C6orf125; Derived by automated computational analysis using gene prediction method: BestRefSeq.
chromosome 26 open reading frame, human C6orf125
ubiquinol-cytochrome-c reductase complex assembly factor 2
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X1
inositol 1,4,5-trisphosphate receptor type 3 isoform X1
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X4
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X2
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X3
inositol 1,4,5-trisphosphate receptor type 3 isoform X4
inositol 1,4,5-trisphosphate receptor type 3 isoform X2
inositol 1,4,5-trisphosphate receptor type 3 isoform X3
uncharacterized LOC121107636, transcript variant X1
uncharacterized LOC121107636, transcript variant X2
uncharacterized LOC768477, transcript variant X2
uncharacterized LOC768477, transcript variant X1
uncharacterized protein LOC768477 isoform X2
uncharacterized protein LOC768477 isoform X1
BCL2 antagonist/killer 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
BCL2 antagonist/killer 1, transcript variant X1
BCL2 antagonist/killer 1, transcript variant X2
bcl-2 homologous antagonist/killer isoform X1
bcl-2 homologous antagonist/killer isoform X2
BCL2 antagonist/killer 1, transcript variant X3
BCL2 antagonist/killer 1, transcript variant X4
bcl-2 homologous antagonist/killer isoform X3
bcl-2 homologous antagonist/killer isoform X4
translocator protein 2, transcript variant X1
translocator protein 2, transcript variant X2
apolipoprotein B mRNA editing enzyme catalytic subunit 2
O-acyl-ADP-ribose deacylase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
O-acyl-ADP-ribose deacylase 1, transcript variant X1
O-acyl-ADP-ribose deacylase 1, transcript variant X2
ADP-ribose glycohydrolase OARD1 isoform X1
nuclear transcription factor Y subunit alpha; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
nuclear transcription factor Y subunit alpha, transcript variant 1
nuclear transcription factor Y subunit alpha, transcript variant 2
nuclear transcription factor Y subunit alpha, transcript variant 3
nuclear transcription factor Y subunit alpha, transcript variant 4
nuclear transcription factor Y subunit alpha, transcript variant X10
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X5
nuclear transcription factor Y subunit alpha, transcript variant X6
nuclear transcription factor Y subunit alpha, transcript variant X7
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X8
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha, transcript variant X4
nuclear transcription factor Y subunit alpha, transcript variant X9
nuclear transcription factor Y subunit alpha, transcript variant X14
nuclear transcription factor Y subunit alpha, transcript variant X20
nuclear transcription factor Y subunit alpha, transcript variant X16
nuclear transcription factor Y subunit alpha, transcript variant X25
nuclear transcription factor Y subunit alpha, transcript variant X12
nuclear transcription factor Y subunit alpha, transcript variant X18
nuclear transcription factor Y subunit alpha, transcript variant X27
nuclear transcription factor Y subunit alpha, transcript variant X11
nuclear transcription factor Y subunit alpha, transcript variant X17
nuclear transcription factor Y subunit alpha, transcript variant X26
nuclear transcription factor Y subunit alpha, transcript variant X15
nuclear transcription factor Y subunit alpha, transcript variant X19
nuclear transcription factor Y subunit alpha, transcript variant X24
nuclear transcription factor Y subunit alpha, transcript variant X22
nuclear transcription factor Y subunit alpha isoform X1
nuclear transcription factor Y subunit alpha isoform X5
nuclear transcription factor Y subunit alpha isoform X6
nuclear transcription factor Y subunit alpha isoform X7
nuclear transcription factor Y subunit alpha isoform X3
nuclear transcription factor Y subunit alpha isoform X8
nuclear transcription factor Y subunit alpha isoform X2
nuclear transcription factor Y subunit alpha isoform X4
nuclear transcription factor Y subunit alpha, transcript variant X13
nuclear transcription factor Y subunit alpha, transcript variant X21
nuclear transcription factor Y subunit alpha isoform 1
nuclear transcription factor Y subunit alpha isoform X9
nuclear transcription factor Y subunit alpha isoform X13
nuclear transcription factor Y subunit alpha isoform X22
nuclear transcription factor Y subunit alpha isoform X11
nuclear transcription factor Y subunit alpha isoform X15
nuclear transcription factor Y subunit alpha isoform X24
nuclear transcription factor Y subunit alpha isoform X10
nuclear transcription factor Y subunit alpha isoform X14
nuclear transcription factor Y subunit alpha isoform 2
nuclear transcription factor Y subunit alpha isoform X23
nuclear transcription factor Y subunit alpha isoform X12
nuclear transcription factor Y subunit alpha isoform X16
nuclear transcription factor Y subunit alpha isoform X21
nuclear transcription factor Y subunit alpha isoform X18
isoform 3 is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
nuclear transcription factor Y subunit alpha isoform 3
nuclear transcription factor Y subunit alpha isoform X19
isoform 4 is encoded by transcript variant 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
nuclear transcription factor Y subunit alpha isoform 4
nuclear transcription factor Y subunit alpha isoform X17
nuclear transcription factor Y subunit alpha, transcript variant X23
nuclear transcription factor Y subunit alpha, transcript variant X28
nuclear transcription factor Y subunit alpha isoform X20
nuclear transcription factor Y subunit alpha isoform X25
uncharacterized LOC107055180, transcript variant X1
triggering receptor expressed on myeloid cells B1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
triggering receptor expressed on myeloid cells B1, transcript variant X2
triggering receptor expressed on myeloid cells B1, transcript variant X3
triggering receptor expressed on myeloid cells B1, transcript variant X4
triggering receptor expressed on myeloid cells B1, transcript variant X1
triggering receptor expressed on myeloid cells B1
triggering receptor expressed on myeloid cells B1 precursor
triggering receptor expressed on myeloid cells B1 isoform X2
triggering receptor expressed on myeloid cells B1 isoform X3
triggering receptor expressed on myeloid cells B1 isoform X1
triggering receptor expressed on myeloid cells 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
triggering receptor expressed on myeloid cells 2
triggering receptor expressed on myeloid cells 2 precursor
TREM-B2; TREM-B2V1; TREM-B2V2; TREM-B2v3; TREML2
triggering receptor expressed on myeloid cells B2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
triggering receptor expressed on myeloid cells B2, transcript variant 1
triggering receptor expressed on myeloid cells B2, transcript variant 3
triggering receptor expressed on myeloid cells B2, transcript variant 2
triggering receptor expressed on myeloid cells isoform 2 precursor
triggering receptor expressed on myeloid cells isoform 2
triggering receptor expressed on myeloid cells isoform 1 precursor
triggering receptor expressed on myeloid cells isoform 3 precursor
MyoD family inhibitor, transcript variant X1
transcription factor EB; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001030922.1
The RefSeq transcript has 11 substitutions, 1 frameshift, 4 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001026093.1
The RefSeq protein has 1 substitution, 1 frameshift compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
progastricsin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_204877.2
similar to AA sequence (same species):RefSeq:NP_990208.1
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
fibroblast growth factor receptor substrate 3, transcript variant X15
fibroblast growth factor receptor substrate 3, transcript variant X14
fibroblast growth factor receptor substrate 3, transcript variant X2
fibroblast growth factor receptor substrate 3, transcript variant X3
fibroblast growth factor receptor substrate 3, transcript variant X13
fibroblast growth factor receptor substrate 3, transcript variant X9
fibroblast growth factor receptor substrate 3, transcript variant X12
fibroblast growth factor receptor substrate 3, transcript variant X8
fibroblast growth factor receptor substrate 3, transcript variant X5
fibroblast growth factor receptor substrate 3, transcript variant X11
fibroblast growth factor receptor substrate 3, transcript variant X6
fibroblast growth factor receptor substrate 3, transcript variant X10
fibroblast growth factor receptor substrate 3, transcript variant X7
fibroblast growth factor receptor substrate 3, transcript variant X4
fibroblast growth factor receptor substrate 3, transcript variant X1
fibroblast growth factor receptor substrate 3 isoform X1
prickle planar cell polarity protein 4, transcript variant X2
prickle planar cell polarity protein 4, transcript variant X1
platelet binding protein GspB-like, transcript variant X4
platelet binding protein GspB-like, transcript variant X2
platelet binding protein GspB-like, transcript variant X1
platelet binding protein GspB-like, transcript variant X3
uncharacterized protein LOC101749017 isoform X1
translocase of outer mitochondrial membrane 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
translocase of outer mitochondrial membrane 6
mitochondrial import receptor subunit TOM6 homolog
ubiquitin specific peptidase 49, transcript variant X2
ubiquitin specific peptidase 49, transcript variant X1
ubiquitin specific peptidase 49, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 20 ESTs, 31 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 49 isoform X1
ubiquitin specific peptidase 49, transcript variant X4
ubiquitin specific peptidase 49, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 49 isoform X2
mediator complex subunit 20; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
mediator complex subunit 20, transcript variant X1
mediator complex subunit 20, transcript variant X2
mediator of RNA polymerase II transcription subunit 20
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator complex subunit 20, transcript variant X3
mediator of RNA polymerase II transcription subunit 20 isoform X2
cyclin D3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
TATA-box binding protein associated factor 8; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
TATA-box binding protein associated factor 8, transcript variant X1
TATA-box binding protein associated factor 8, transcript variant X2
TATA-box binding protein associated factor 8
TATA-box binding protein associated factor 8, transcript variant X3
transcription initiation factor TFIID subunit 8 isoform X1
transcription initiation factor TFIID subunit 8 isoform X2
transcription initiation factor TFIID subunit 8
propagated from UniProtKB/Swiss-Prot (Q5ZMS1.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (Q5ZMS1.1); Region: Nuclear localization signal. /evidence=ECO:0000255
chitinase, acidic; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC107055171, transcript variant X2
uncharacterized LOC107055171, transcript variant X1
uncharacterized LOC107055171, transcript variant X3
uncharacterized LOC107055172, transcript variant X2
uncharacterized LOC107055172, transcript variant X1
uncharacterized LOC107055172, transcript variant X3
fibromodulin; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (P51887.1)
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P51887.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 1
N-linked (GlcNAc...) (keratan sulfate) asparagine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P51887.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 2
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 3
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 4
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 5
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 6
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 7
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 8
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 9
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 10
propagated from UniProtKB/Swiss-Prot (P51887.1); Region: LRR 11
proline and arginine rich end leucine rich repeat protein, transcript variant X1
proline and arginine rich end leucine rich repeat protein, transcript variant X2
opticin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ATPase plasma membrane Ca2+ transporting 4, transcript variant X11
ATPase plasma membrane Ca2+ transporting 4, transcript variant X1
ATPase plasma membrane Ca2+ transporting 4, transcript variant X6
ATPase plasma membrane Ca2+ transporting 4, transcript variant X13
ATPase plasma membrane Ca2+ transporting 4, transcript variant X5
ATPase plasma membrane Ca2+ transporting 4, transcript variant X10
ATPase plasma membrane Ca2+ transporting 4, transcript variant X12
ATPase plasma membrane Ca2+ transporting 4, transcript variant X9
ATPase plasma membrane Ca2+ transporting 4, transcript variant X3
ATPase plasma membrane Ca2+ transporting 4, transcript variant X2
ATPase plasma membrane Ca2+ transporting 4, transcript variant X7
ATPase plasma membrane Ca2+ transporting 4, transcript variant X4
ATPase plasma membrane Ca2+ transporting 4, transcript variant X8
plasma membrane calcium-transporting ATPase 4 isoform X1
plasma membrane calcium-transporting ATPase 4 isoform X3
plasma membrane calcium-transporting ATPase 4 isoform X2
plasma membrane calcium-transporting ATPase 4 isoform X5
plasma membrane calcium-transporting ATPase 4 isoform X6
plasma membrane calcium-transporting ATPase 4 isoform X7
plasma membrane calcium-transporting ATPase 2 isoform X4
uncharacterized LOC124417405, transcript variant X1
uncharacterized LOC124417405, transcript variant X2
microRNA 7454; Derived by automated computational analysis using gene prediction method: BestRefSeq.